ACG Chicago’s Post

A snapshot of the problem in the women's health space: 🌱 Investment: Women’s health digital start-ups account for just 3% of overall digital health funding. 🔬R&D: Although women account for 70% of chronic pain patients, 80% of pain medication has been tested only on men or male mice. ♂️ 📚Education: 41% of UK medical schools do not have mandatory menopause education on the curriculum. ⚕️Diagnosis: On average, women wait 4 years longer than men to receive a diagnosis for the same disease. - 📢 If you haven't heard yet, the [w]Health community at Kearney invites all those within the #healthcare ecosystem whose innovations have impact and decisions have power: from pharma, biotech, and medtech firms to investors, tech companies, and consumer health players to redesign healthcare with the #women and #girls in mind. Join our community meeting on July 17th, 4pm - 5pm CEST to learn more about [w]Health and discuss opportunities to come together and collaborate! ⭐ Here's to empowering women's health, together. 💜 RSVP here 👇 https://lnkd.in/dwdR_AG9 -- Join our [w]Health community: https://lnkd.in/dV-5EPtX

"Women’s health is no longer a niche—it's a powerful, growing market with untapped potential. But where are the real opportunities, and what should investors watch out for?" Last week, we explored key trends and insights in women’s health, from major acquisitions to promising new funding rounds. Here are some highlights: 🔦 Hologic’s $350M acquisition of Gynesonics expands minimally invasive solutions for treating heavy periods and fibroids. 💡 FemmeMeno secured €761,829 to develop supplements that support women during peri/menopause—another step forward for women’s health. 📊 Key Insights: Fertility services, MFM tech, and digital innovations are presenting bright spots, while privacy and regulatory concerns require careful navigation. The Future of Women’s health is evolving. Curious to know more? 📲 Click the link to read the full round-up and get the latest updates. https://smpl.is/9r3pw #WomensHealth #InvestmentInsights #HealthcareInnovation #Femtech #PrivateEquity

Did you know: On average, women spend 25% more time in “poor health”? Healthcare access is less than half of the problem. The main reason is the gender gap in medical effectiveness. Men and women experience important differences in the effectiveness of medicines designed and approved for use by both. Often, women are at a disadvantage. For example, Asthma, which affects both men and women at a similar prevalence rate, is predominantly treated with inhaler therapy with bronchodilators and corticosteroids. However, studies indicate that this treatment is around 20 percentage points less effective for women than men. Unfortunately, there are several more such examples. Women are underrepresented in trials; only about 5% of trials report the number of participants by gender. Women’s health is under-invested and under-researched, e.g., there were five times more scientific studies on erectile dysfunction than premenstrual syndrome in 2015. Private investments in women’s health have increased recently, as the opportunity is becoming clearer. However, policy and incentive interventions are necessary to ensure gender-specific data tracking and higher investments in women’s health.

The future of women’s health is evolving. But where are the real opportunities? And what should investors watch out for? Notes to Selfe unpacks the latest in the Weekly Women’s Health Investing Roundup👇 #WomensHealth #Femtech #WomeninVC #InvestmentInsights

🌟 Key Insights from "Can Fibroids Mask Other Issues?" 🌟 I attended a thought-provoking talk hosted by Sateria Venable, CEO of the The Fibroid Foundation featuring @ Dr. Candice Jones-Cox from Walter Reed and @Dr. Linda Bradley from Cleveland Clinic. The session shone a light on the often-overlooked impact of #fibroids on #women's #health and the critical need for comprehensive #gynecological #screenings. The experts illustrated how #fibroids could mask more severe health conditions, highlighting the essential role of open discussions with healthcare providers about all #symptoms, regardless of treatment plans. Thanks to Sateria Venable for her enlightening insights and to the doctors for their invaluable guidance. This discussion is a stark reminder of the importance of being #proactive about #women’s #health. 📢 Let's #Amplify #Awareness! Share this post to spread the word about the necessity of thorough women’s health screenings. Together, we can elevate the conversation around #fibroids, #endometriosis, and more, ensuring that #women everywhere are #empowered to take charge of their health. #WomensHealth #FibroidsAwareness #Gynecology #Healthcare #FibroidFoundation #Leadership #empowerUs #fibroidMaze

The current healthcare system tends to view the male body as “default,” which means women’s health needs are often dismissed, downplayed, or deprioritized. It's hard to believe this is the status quo in 2024, but here we are. In a recent guest column for Clinical Leader, Juan Camilo Arjona Ferreira, chief medical officer, Organon, argues that increasing women’s roles in clinical research is key to investment, engagement, and equity. Ferreira provides a three-step model designed to “drive forward important changes needed to advanced research in overlooked areas.” Here’s hoping that more biopharmas and medtechs will heed (and implement) this advice. Source: https://hubs.li/Q02mCrbd0 #womenshealthcare #womenshealth #investment #enagement #equity #genderbiases #womenshealthmatters

🌟 New Report Release: Digital Health 🌟 FemHealth Insights is thrilled to announce the publication of our latest comprehensive report on "Digital Health". This meticulously crafted analysis provides in-depth insights into the evolving landscape of digital health technologies and their impact on women's health. 🔍 Key Highlights Include: - Emerging trends in digital health solutions for women - Innovative companies shaping the future of women’s health - Insights on geographical distribution of companies - Company exits and funding landscape within digital health companies As a leader in health innovation, this report is an indispensable resource for professionals seeking to navigate the complexities of the digital health market and drive impactful change in women's health. 👉 Purchase the report now: https://lnkd.in/emamgKFM #DigitalHealth #WomensHealth #HealthTech #Innovation #FemHealthInsights #Dr.B

Subgroup analysis is a statistical technique used in research and clinical trials to explore whether the effects of a treatment or intervention differ across different groups of subjects within a study population. Subgroups are defined based on certain characteristics or variables, and the goal is to examine whether the treatment effect is consistent across these subgroups or if there are variations in the response to the intervention. For example, whether treatment is more or less effective in women or treatment effectiveness is better or worse among older people.   #ActuReal #WordofTheDay #Healthcare #SubgroupAnalysis

How do we close the gap in women's #cardiovascular health? An excellent panel of formidable experts discussed how females living with #CVD are all too often under-diagnosed, under-treated and under-represented in clinical trials. More research, more data, and better education among community and healthcare providers is crucial. #worldheartsummit #herheartmatters Celina Gorre Dr. ShantaQuilette (Dr. Q) Develle, MBA, CPLC, MH, EA Dr Mariell Jessup, Neil Johnson, Alicia Chong Rodriguez, Gabriela Melo Ghisi

🔍 New Report Highlights Critical Advances in Uterine Health FemHealth Insights is proud to present our latest report on the uterine health market, a vital sector addressing key women's health challenges such as endometriosis and uterine fibroids. Our findings reveal that over 60% of companies within this sector are now focusing on the diagnostics, treatment, and management of endometriosis, highlighting a significant shift towards tackling this pervasive condition. 🔗 Ensure you're informed on the latest developments in uterine health by purchasing your copy today: https://loom.ly/dVFvzkE #UterineHealth #EndometriosisAwareness #FemTech #HealthcareInnovation #MarketInsights #FemHealthInsights